Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 7 of 7 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABP 959 - biosimilar to eculizumab | 1件: Eculizumab Eculizumab (Eculizumab) | 1件: Eculizumab
Eculizumab
(Eculizumab, Eculizumab) 💬1. ABP 959 - biosimilar to eculizumab
| 1件: C5 C5 💬1. ABP 959 - biosimilar to eculizumab
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬1. ABP 959 - biosimilar to eculizumab
| ||||||||||||||||||||||||||||||||
| 2 | ABP 959 - proposed biosimilar to eculizumab | 1件: Eculizumab Eculizumab (Eculizumab) | 1件: Eculizumab
Eculizumab
(Eculizumab, Eculizumab) 💬2. ABP 959 - proposed biosimilar to eculizumab
| 1件: C5 C5 💬2. ABP 959 - proposed biosimilar to eculizumab
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬2. ABP 959 - proposed biosimilar to eculizumab
| ||||||||||||||||||||||||||||||||
| 3 | ECULIZUMAB | 1件: Eculizumab Eculizumab (Eculizumab) | 1件: Eculizumab
Eculizumab
(Eculizumab, Eculizumab) 💬3. ECULIZUMAB
| 1件: C5 C5 💬3. ECULIZUMAB
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 7件: 11 11, 13, 14, 61, 62, 109, 222 💬3. ECULIZUMAB
| ||||||||||||||||||||||||||||||||
| 4 | SB12 (proposed eculizumab biosimilar) | 1件: Eculizumab Eculizumab (Eculizumab) | 1件: Eculizumab
Eculizumab
(Eculizumab, Eculizumab) 💬4. SB12 (proposed eculizumab biosimilar)
| 1件: C5 C5 💬4. SB12 (proposed eculizumab biosimilar)
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬4. SB12 (proposed eculizumab biosimilar)
| ||||||||||||||||||||||||||||||||
| 5 | Soliris (eculizumab) | 1件: Eculizumab Eculizumab (Eculizumab) | 1件: Eculizumab
Eculizumab
(Eculizumab, Eculizumab) 💬5. Soliris (eculizumab)
| 1件: C5 C5 💬5. Soliris (eculizumab)
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬5. Soliris (eculizumab)
| ||||||||||||||||||||||||||||||||
| 6 | Soliris ™ (eculizumab) | 1件: Eculizumab Eculizumab (Eculizumab) | 1件: Eculizumab
Eculizumab
(Eculizumab, Eculizumab) 💬6. Soliris ™ (eculizumab)
| 1件: C5 C5 💬6. Soliris ™ (eculizumab)
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬6. Soliris ™ (eculizumab)
| ||||||||||||||||||||||||||||||||
| 7 | SOLIRIS® (eculizumab) injection, for intravenous use | 1件: Eculizumab Eculizumab (Eculizumab) | 1件: Eculizumab
Eculizumab
(Eculizumab, Eculizumab) 💬7. SOLIRIS® (eculizumab) injection, for intravenous use
| 1件: C5 C5 💬7. SOLIRIS® (eculizumab) injection, for intravenous use
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, H ... | 1件: 62 62 💬7. SOLIRIS® (eculizumab) injection, for intravenous use
|